Thursday, Oct 16 / 2025
  • Thursday, October 16, 2025
  • 10:00 AM - 12:00 PM PST
Download for Outlook/Apple Calendar Add to Google Calendar

October Virtual Investor Forum

K4SoCal October 2015

The forum will feature 20-minute presentations (including Q&A) from a curated selection of exciting start-up companies, all carefully selected through our screening processes. You will also see updated presentations from past presenting companies.

TBD

Presenting companies:

Omega Power Batteries Corp.
Omega Power Batteries Corp.

Pilot scale production of Omega Power Safe™ fireproof batteries will lead to a fast-track to revenue with their U.S. based manufacturing partnerships. Follow on Series A funding of $25M will lead to commercial scale production capacity to ramp up annual revenue to over $100M. This gives Omega Power a first-movers advantage in targeting the non-EV, power hungry AI robotics and drone markets, prioritizing safety, using their licensed and patented components and proprietary non-flammable electrolyte to supply these highly profitable, yet underserved market segments looking to transition to a “Made in America” cell supplier to avoid tariff and supply chain risks.

Manium Brands (DBA Freak Shake)
Manium Brands (DBA Freak Shake)

Freak Shake Endurance fuels the most resilient humans on earth. Led by a 20-year CPG veteran, its UCSD grant-backed nutrition targets the aerobic machinery inside cells to fight fatigue and aid recovery. Endurance training uniquely stresses athletes, but these needs remain overlooked by a category bloated with bro-tein, vanity brands, and questionable ingredients.

DIMERx
DIMERx

DIMERx is an NIH-backed, clinical-stage biotech developing first-in-class, non-addictive pain therapeutics that treat pain without addiction or abuse. Our lead program, DMX-101, a peripherally acting buprenorphine dimer, offers a de-risked, late-stage asset addressing the $100 B global pain market—combining strong clinical validation, federal support, and rapid path to value creation.

SkinIO
SkinIO

SkinIO delivers scalable skin cancer detection and connection to care using a proprietary AI platform integrated with board-certified dermatologist reviews. The solution focuses on full-body screening via smartphone or tablet, with rapid diagnosis and care access, aiming to democratize high-quality skin cancer assessment.